UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

BMC cancer, 2021-05, Vol.21 (1), p.578-578, Article 578

2021

Volltextzugriff (PDF)

Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

Annals of oncology, 2023-12, Vol.34 (12), p.1175-1186

2023

Volltextzugriff (PDF)

Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data

Critical reviews in oncology/hematology, 2018-12, Vol.132, p.138-144

2018

Volltextzugriff (PDF)

Acute leukoencephalopathy and thyroiditis induced by capecitabine

Acta neurologica Belgica, 2022-10, Vol.122 (5), p.1373-1375

2022

Volltextzugriff (PDF)

Palmar fasciitis and polyarthritis, a rare paraneoplastic syndrome related to ovarian cancer

Clinical and experimental dermatology, 2017-04, Vol.42 (3), p.328-330

2017

Volltextzugriff (PDF)

Retrospective analysis of definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: 2-year outcome

European journal of cancer (1990), 2017-02, Vol.72, p.S106-S106

2017

Volltextzugriff (PDF)

2858 Definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: A retrospective analysis

European journal of cancer (1990), 2015-09, Vol.51, p.S575-S575

2015

Volltextzugriff (PDF)

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future

ESMO open, 2022-12, Vol.7 (6), p.100610-100610, Article 100610

2022

Volltextzugriff (PDF)

Acute liver failure secondary to metastatic liver infiltration: case report and review of the literature

Acta gastro-enterologica belgica, 2013-12, Vol.76 (4), p.436-438

2013

Volltextzugriff (PDF)

A LESER-TRÉLAT SIGN INDICATING MULTIPLE GASTROINTESTINAL NEOPLASIA

Acta clinica belgica (English ed. Online), 2013-09, Vol.68 (5), p.391-392

2013

Volltextzugriff (PDF)

Diabetic lumbosacral radiculoplexus neuropathy in an older patient

European geriatric medicine, 2014-04, Vol.5 (2), p.127-128

2014

Volltextzugriff (PDF)

P-24 Circulating tumor DNA as a marker of Minimal Residual Disease in squamous cell carcinoma of the head and neck: an agnostic approach

Oral oncology, 2021-07, Vol.118, p.11-11

2021

Volltextzugriff (PDF)

141P The causes and consequences of incomplete paclitaxel administration during the neoadjuvant treatment of early triple-negative and HER2 positive breast cancer (CIPNETH)

ESMO open, 2024-05, Vol.9, p.103128, Article 103128

2024

Volltextzugriff (PDF)

889 - Retrospective analysis of definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: 2-year outcome

European journal of cancer (1990), 2017-02, Vol.72, p.S106-S106

2017

Volltextzugriff (PDF)

923P Tumor-informed ctDNA assay to predict recurrence in locally advanced SCCHN

Annals of oncology, 2024-09, Vol.35, p.S646-S646

2024

Volltextzugriff (PDF)

A LESER-TRÉ;LAT SIGN INDICATING MULTIPLE GASTROINTESTINAL NEOPLASIA

Acta clinica belgica (English ed. Online), 2013-09, Vol.68 (5), p.391

2013

Volltextzugriff (PDF)

296P Identification of metabolism-related therapeutic targets to improve response to neoadjuvant chemotherapy in early breast cancers

Annals of oncology, 2023-10, Vol.34, p.S302-S302

2023

Volltextzugriff (PDF)

858O Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival

Annals of oncology, 2023-10, Vol.34, p.S556-S557

2023

Volltextzugriff (PDF)

1990MO Sacituzumab govitecan (SG) as second-line (2L) treatment for extensive stage small cell lung cancer (ES-SCLC): Preliminary results from the phase II TROPiCS-03 basket trial

Annals of oncology, 2023-10, Vol.34, p.S1061-S1062

2023

Volltextzugriff (PDF)

181P GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative

Annals of oncology, 2023-10, Vol.34, p.S253-S254

2023

Volltextzugriff (PDF)

1157P - Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2019-10, Vol.30, p.v468-v469

2019

Volltextzugriff (PDF)

Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2019-10, Vol.30, p.v468-v469

2019

Volltextzugriff (PDF)

1157PLiquid biopsy for mutational profiling of locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

206P Characterization of the immune microenvironment of recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) that progress on or after platinum and anti-PD(L)1 therapies: An EORTC IMMUcan sub-project

Immuno-oncology technology, 2022-12, Vol.16, p.100317, Article 100317

2022

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(12)
Humans
(9)
Oncology
(5)
Technology
(4)
Belgium
(3)
Biomarkers, Tumor - Genetics
(3)
Female
(3)
Male
(3)
Aged
(2)
Aged, 80 And Over
(2)
Biophysics
(2)
Cancer
(2)
Cancer Research
(2)
Covid-19
(2)
Engineering Geology
(2)
Environmental Geology
(2)
Europe
(2)
Fatal Outcome
(2)
Hades Underground Research Laboratory
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data

Acute leukoencephalopathy and thyroiditis induced by capecitabine

Palmar fasciitis and polyarthritis, a rare paraneoplastic syndrome related to ovarian cancer

Retrospective analysis of definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: 2-year outcome

2858 Definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: A retrospective analysis

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

Acute liver failure secondary to metastatic liver infiltration: case report and review of the literature

A LESER-TRÉLAT SIGN INDICATING MULTIPLE GASTROINTESTINAL NEOPLASIA

Diabetic lumbosacral radiculoplexus neuropathy in an older patient

P-24 Circulating tumor DNA as a marker of Minimal Residual Disease in squamous cell carcinoma of the head and neck: an agnostic approach

141P The causes and consequences of incomplete paclitaxel administration during the neoadjuvant treatment of early triple-negative and HER2 positive breast cancer (CIPNETH)

889 - Retrospective analysis of definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: 2-year outcome

923P Tumor-informed ctDNA assay to predict recurrence in locally advanced SCCHN

A LESER-TRÉ;LAT SIGN INDICATING MULTIPLE GASTROINTESTINAL NEOPLASIA

296P Identification of metabolism-related therapeutic targets to improve response to neoadjuvant chemotherapy in early breast cancers

858O Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival

1990MO Sacituzumab govitecan (SG) as second-line (2L) treatment for extensive stage small cell lung cancer (ES-SCLC): Preliminary results from the phase II TROPiCS-03 basket trial

181P GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative

1157P - Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck

Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck

1157PLiquid biopsy for mutational profiling of locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck

206P Characterization of the immune microenvironment of recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) that progress on or after platinum and anti-PD(L)1 therapies: An EORTC IMMUcan sub-project

Suchergebnisse filtern